Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Share News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,830.00
Bid: 1,848.00
Ask: 1,860.00
Change: -38.00 (-2.03%)
Spread: 12.00 (0.649%)
Open: 1,830.00
High: 1,860.00
Low: 1,830.00
Prev. Close: 1,868.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Genus Posts "Very Strong" Interim Results Despite Covid-19 Impact

Thu, 25th Feb 2021 09:42

(Alliance News) - Genus PLC on Thursday reported a "very strong" performance" and made "good" strategic progress in the first half of its 2021 financial year.

The Basingstoke, Hampshire-based company sells products made using biotechnology to cattle and pig farmers. It recorded revenue for the six moths ended December 31 of GBP285.7 million, a rise of 6% from GBP270.7 million in 2019.

Pretax profit for the period was GBP38.7 million, a substantial increase of 27% from GBP30.4 million in 2019.

Genus said these increases are due to a "strong" revenue growth of 6% in actual currency and 11% in constant currency. Its porcine genetics business saw an 8% increase, while its bovine genetics business grew by 17%, particularly in Brazil, Russia, India and China.

As a result of "strong earnings growth and cash flow generation", the company has declared an interim dividend of 10.3 pence, which is a 10% increase from 9.4p the previous year.

Shares in Genus were down 4.9% at 4,984.98p in London on Thursday.

"The group continued to show its resilience during the Covid-19 pandemic. Both PIC and ABS grew adjusted operating profits in double digits, with China, Brazil, India and Russia, being notably high growth markets. The porcine genetics business' expansion in China was significant, gaining share with large producers that have been re-stocking following the spread of African Swine Fever in 2019. Europe's growth was also very strong reflecting success with key accounts, leveraging our genetics and supply chain," said Chief Executive Stephen Wilson.

"The bovine genetics business' volume growth in the half was a record, driven by the continued success of Sexcel, and strong performance by our proprietary NuEra beef business. Latin America, Europe and Asia all grew strongly, and ABS's adjusted operating margin improved through better product mix and operating leverage," Wilson added.

Looking ahead, Genus said it will remain "resilient" as the the Covid-19 pandemic continues and expects trading to be in line with its 2021 expectations.

"In the second half of the 2021 fiscal year, we expect that growth will be lower and there are increased currency headwinds. Nevertheless, Genus continues to have significant growth opportunities and the board's expectations remain unchanged for the full year," Wilson said.

By Zoe Wickens; zoewickens@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Apr 2020 09:33

UK BROKER RATINGS SUMMARY: HSBC Raises M&B, Marston's And Wetherspoon

UK BROKER RATINGS SUMMARY: HSBC Raises M&B, Marston's And Wetherspoon

Read more
26 Mar 2020 16:13

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
23 Mar 2020 16:58

FTSE 250 movers: Precious metals miners gain, Plus500 jumps

(Sharecast News) - Precious metals miners Hochschild Mining and Petropavlovsk were both wanted at the start of the week, as the US central bank in effect shifted to a policy of unlimited asset purchases, as some analysts had correctly anticipated.

Read more
4 Mar 2020 15:59

FTSE 250 movers: Genus jumps, Restaurant Group slumps

(Sharecast News) - Genus shares hit a fresh record high on the back of an update from sausage skin manufacturer Devro which reported that its factory in Nantong, China, had returned to normal production.

Read more
27 Feb 2020 16:08

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
27 Feb 2020 11:14

Genus sees strong revenue growth in first half

(Sharecast News) - Animal genetics company Genus reported "strong" revenue growth of 13% in actual and constant currency in its half-year results on Thursday, to ?270.7m.

Read more
27 Feb 2020 10:15

Genus Turns To Interim Profit And Lifts Dividend, Backs Annual Outlook

Genus Turns To Interim Profit And Lifts Dividend, Backs Annual Outlook

Read more
20 Feb 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
28 Nov 2019 09:41

UK BROKER RATINGS SUMMARY: Morgan Stanley Upgrades Property Investors

UK BROKER RATINGS SUMMARY: Morgan Stanley Upgrades Property Investors

Read more
22 Nov 2019 16:06

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
20 Nov 2019 08:48

Former Compass Group Finance Executive Henriksen Joins Genus As CFO

Former Compass Group Finance Executive Henriksen Joins Genus As CFO

Read more
20 Nov 2019 08:01

Genus names Alison Henriksen as CFO

(Sharecast News) - Animal genetics business Genus named Alison Henriksen as its next chief financial officer on Wednesday.

Read more
15 Nov 2019 13:09

Friday broker round-up

(Sharecast News) - Whitbread: Barclays upgrades to overweight with a target price of 4,900p.

Read more
15 Nov 2019 09:30

UK BROKER RATINGS SUMMARY: Berkeley Gets Cut; Barclays Likes Whitbread

UK BROKER RATINGS SUMMARY: Berkeley Gets Cut; Barclays Likes Whitbread

Read more
14 Nov 2019 13:10

Thursday broker round-up

(Sharecast News) - Tullow Oil: Jefferies downgrades to hold with a target price of 168p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.